The current valuation score of Myriad Genetics Inc is 8.29, ranking 98 out of 203 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.99, which is -16.47% below the recent high of -0.82 and -2084.82% above the recent low of -21.52.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.